Clinical Trial Update: Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD [Phase 3]

View source ↗

Summary

Open-label Phase 3 study evaluating long-term tolerability and safety of atomoxetine in children with fetal alcohol syndrome and ADHD; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Fetal Alcohol Syndrome

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Oklahoma | Conditions: Fetal Alcohol Syndrome, Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | Status: COMPLETED | Results posted: 2017-07-02